The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Bioartificial livers: a review of their design and manufacture
Abstract
Acute liver failure (ALF) is a rapidly progressive disease with high morbidity and mortality rates. Liver transplantation and artificial liver (AL) support systems, such as ALs and bioartificial livers (BALs), are the two major therapies for ALF. Compared to ALs, BALs are composed of functional hepatocytes that provide essential liver functions, including detoxification, metabolite synthesis, and biotransformation. Furthermore, BALs can potentially provide effective support as a form of bridging therapy to liver transplantation or spontaneous recovery for patients with ALF. In this review, we systematically discussed the currently available state-of-the-art designs and manufacturing processes for BAL support systems. Specifically, we classified the cell sources and bioreactors that are applied in BALs, highlighted the advanced technologies of hepatocyte culturing and bioreactor fabrication, and discussed the current challenges and future trends in developing next-generation BALs for large-scale clinical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In BAL systems, FBBs work similarly by continuously perfusing culture medium or plasma to provide a dynamic, suspended, 3D culture environment for encapsulated liver cells or spheroids, promoting efficient material exchange [193, 194].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [193]
Citations
Cites
1 retracted
Jia, Z., Cheng, Y., Jiang, X., Zhang, C., Wang, G., Xu, J., Li, Y., Peng, Q., & Gao, Y. (2020) · BioMed Research International · doi:10.1155/2020/6354183 · Cited by 29 · cited 1×
“Cellular components in liver tissue microenvironments can also be reproduced and rearranged by co-culturing parenchymal hepatocytes and non-parenchymal cells, such as endothelial cells [153], stellate cells [154], and Kupffer cells [155], in the form of sheets [149] or spheroids [156].”
RetractedThe present and future role of microfluidics in biomedical research
Sackmann, E. K., Fulton, A. L., & Beebe, D. J. (2014) · Nature · doi:10.1038/nature13118 · Cited by 2,995 · cited 1×
“Microfluidics deals with the behavior and manipulation of fluids using a microscale device built with microfabrication technologies [134].”
An overview of thermal energy storage systems
Alva, G., Lin, Y., & Fang, G. (2018) · Energy · doi:10.1016/j.energy.2017.12.037 · Cited by 1,408 · cited 1×
“Generally, as the fluid flow passes from the bottom to the top of a reactor, solid particles can only be supported and remain suspended when the critical flow rate is reached [88].”
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.045 · Cited by 1,172 · cited 2×
“They are simple to manipulate and available for long-term culturing and mass production of spheroids [ 98].”
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
Nath, S., & Devi, G. R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.03.013 · Cited by 919 · cited 1×
“Currently developed techniques such as non-adherent surfaces, hanging drop, and microw-ell arrays, exhibit higher controllability of spheroid formation [161].”
Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting
Ma, X., Qu, X., Zhu, W., Li, Y.-S., Yuan, S., Zhang, H., Liu, J., Wang, P., Lai, C. S. E., Zanella, F., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524510113 · Cited by 872
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X., & Hui, L. (2011) · Nature · doi:10.1038/nature10116 · Cited by 864 · cited 2×
“The direct reprogramming of mouse fibroblasts to hepatic lineages, first reported by Huang et al [67] and Sekiya et al [68] in 2011, can accelerate the production of hepatocytes and circumvent the complex hiPSC differentiation process.”
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors
Sekiya, S., & Suzuki, A. (2011) · Nature · doi:10.1038/nature10263 · Cited by 846
Stravitz, R. T., & Lee, W. M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31894-x · Cited by 844
Research works printed but not linked: 3
- Wu, 2019, Advances in bioartificial liver system, Chin. J. Cell Biol., 41, 594
- Shiraha, 1996, Improvement of serum amino acid profile in hepatic failure with the bioartificial liver using multicellular hepatocyte spheroids, Biotechnol. Bioeng., 50, 416, 10.1002/(sici)1097-0290(19960520)50:4<416::aid-bit8>3.0.co;2-o · doi:10.1002/(sici)1097-0290(19960520)50:4<416::aid-bit8>3.0.co;2-o
- Gu, 2013, Systematic evaluation of extracorporeal bioartificial liver support system for the treatment of liver failure, Chin. J. Tissue Eng. Res., 17, 3374
Cited by
Human organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 156
“Up to now, many parts of the human body have been reproduced with OOCs, such as the brain, lung, gut, liver, kidney, islet, heart and cartilage [10, 11, 13, 69-80].”
BackgroundDeng, B., Ma, Y., Huang, J., He, R., Luo, M., Mao, L., Zhang, E., Zhao, Y., Wang, X., Wang, Q., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado1550 · Cited by 47
Li, G., He, J., Shi, J., Li, X., Liu, L., Ge, X., Chen, W., Jia, J., Wang, J., Yin, M., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-333885 · Cited by 41
Self-citationYadav, P., Singh, S. K., Rajput, S., Allawadhi, P., Khurana, A., Weiskirchen, R., & Navik, U. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108563 · Cited by 40
Zhang, J., Chen, X., Chai, Y., Zhuo, C., Xu, Y., Xue, T., Shao, D., Tao, Y., & Li, M. (2024) · Advanced Science · doi:10.1002/advs.202309899 · Cited by 32
Metadata
- Authors
- Tuerxun, K., He, J., Ibrahim, I., Yusupu, Z., Yasheng, A., Xu, Q., Tang, R., Aikebaier, A., Wu, Y., Tuerdi, M., Nijiati, M., Zou, X., & Xu, T.
- Affiliations
- Ministry of Education of the People's Republic of China (CN)
- Venue
- Biofabrication
- Publisher
- IOP Publishing
- Published
- 2022-06-06
- Volume
- 14
- Issue
- 3
- Pages
- 032003
- ISSN
- 1758-5082 (ISSN-L)
- 1758-5090
- OpenAlex
- W4280558607
- Cited by
- 24
- References
- 173
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 6 · 2023: 4 · 2022: 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- publishingsupport.iopscience.iop.org/iop-standard/v1 (vor)
- iopscience.iop.org/info/page/text-and-data-mining (tdm)
- Locations
- Biofabrication (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Higher Education Discipline Innovation Project (B17026)
- Chaoyang Talent Training Project of the First People’s Hospital of Kashi (KDYY-ZYRC-2020-03)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- bioartificial liver, acute liver failure, artificial liver support, hepatocyte culture, liver transplantation, bridging therapy, biotransformation, detoxification
- MeSH terms
- Humans, Liver Failure, Acute, Bioreactors, Liver, Artificial, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioartificial livers: a review of their design and manufacture. https://app.cochat.ai/papers/10.1088/1758-5090/ac6e86
- The paper
- Tuerxun, K., He, J., Ibrahim, I., Yusupu, Z., Yasheng, A., Xu, Q., Tang, R., Aikebaier, A., Wu, Y., Tuerdi, M., Nijiati, M., Zou, X., & Xu, T. (2022). Bioartificial livers: a review of their design and manufacture. Biofabrication. https://doi.org/10.1088/1758-5090/ac6e86
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.